A recent report demonstrated the downregulation of LINC00612 in COPD tissues and in human pulmonary microvascular endothelial cells (HPMECs) exposed to CSE (Luo et al., 2020). This evidence concerns the gene LINC00612 and chronic obstructive pulmonary disease.